📖

APOE-Expressing Astrocytes

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-apoe-expressing-astrocyt

Related Entities

cell-types-apoe-expressing-astrocytes

Metadata

slug	cell-types-apoe-expressing-astrocytes
entity_type	cell
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (352)

related🧪APOE Isoform Expression Across Glial Subtypes90%

mentions🧫GWAS of plasma NfL in East Asian cohort80%

mentions🧫GWAS of composite biomarker score80%

mentions🧫GWAS of plasma pTau217 in East Asian cohort80%

mentions🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho80%

mentions🧫GWAS of plasma pTau181 in East Asian cohort80%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model80%

mentions🧫GWAS of plasma GFAP in East Asian cohort80%

mentions🧫KEEPS Continuation: Long-term effects of menopausal hormone 80%

mentions🧫APOE4 association with TDP-43 pathology in AD80%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%

mentions🧪Competitive APOE4 Domain Stabilization Peptides80%

mentions🔬Lipid metabolism dysregulation and membrane integrity in Alz75%

mentions🔬Analysis question not specified75%

related🧫GWAS of plasma NfL in East Asian cohort72%

related🧫GWAS of composite biomarker score72%

related🧫GWAS of plasma pTau217 in East Asian cohort72%

related🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho72%

related🧫GWAS of plasma pTau181 in East Asian cohort72%

related🧫RBG treatment in ApoE-/- atherosclerosis mouse model72%

related🧫GWAS of plasma GFAP in East Asian cohort72%

related🧫KEEPS Continuation: Long-term effects of menopausal hormone 72%

related🧫APOE4 association with TDP-43 pathology in AD72%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪Competitive APOE4 Domain Stabilization Peptides70%

mentions🧪APOE Isoform Expression Across Glial Subtypes70%

mentions🧫Real-world safety study of Lecanemab in Japanese AD patients70%

mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%

mentions🧫DDT/DDE exposure and cognitive function in Latina women70%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

mentions🧫ApoE4 Function in Alzheimer's Disease70%

mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%

mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD70%

mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera70%

mentions🧫Genetic Risk Modifiers in DLB Phenotype70%

mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%

mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%

mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%

mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%

mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%

mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%

mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%

mentions🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati70%

mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%

mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A70%

mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol70%

mentions🧫Viral Infections and Alzheimer's Disease — causal mecha70%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%

related🧫Blood-Based Biomarker Panel for Early AD Detection70%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%

related🧫Blood-Based Biomarker Panel for Early AD Detection70%

related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and70%

related🔬Lipid metabolism dysregulation and membrane integrity in Alz67%

related🔬Analysis question not specified67%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE65%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 65%

see_also📖nct0550878965%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739265%

see_also📖remternetug-anti-amyloid-alzheimers65%

see_also📖UPenn Observational Research Repository (NCT04715399)65%

see_also📖APOE2 (Apolipoprotein E2)65%

see_also📖APOE3 (Apolipoprotein E3)65%

see_also📖APOE4 (Apolipoprotein E4)65%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer63%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones63%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction63%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

related🧪Competitive APOE4 Domain Stabilization Peptides63%

related🧫Real-world safety study of Lecanemab in Japanese AD patients63%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%

related🧫DDT/DDE exposure and cognitive function in Latina women63%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%

related🧫ApoE4 Function in Alzheimer's Disease63%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD63%

related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera63%

related🧫Genetic Risk Modifiers in DLB Phenotype63%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%

related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin63%

related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise63%

related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%

related🧫Neural Stem Cell Therapy for Alzheimer's Disease63%

related🧫Normal Aging to Alzheimer's Disease Transition Trigger 63%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%

related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati63%

related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%

related🧫Vascular Contribution to Alzheimer's Disease — Beyond A63%

related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol63%

related🧫Viral Infections and Alzheimer's Disease — causal mecha63%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration60%

see_also📖Exosomal Biomarkers in Neurodegeneration60%

see_also📖Exosomal miR-155 in Neurodegeneration60%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration60%

see_also📖Liquid Biopsy in Neurodegeneration60%

see_also📖Metabolomic Biomarkers in Neurodegeneration60%

see_also📖Neuroimaging Biomarkers for Neurodegeneration60%

see_also📖Synaptic Biomarkers in Neurodegeneration60%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and60%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl60%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 60%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)60%

see_also📖China Neurodegeneration Epidemiology60%

see_also📖DALY Methodology — Neurodegeneration60%

see_also📖Disease Progression & Staging in Neurodegeneration60%

see_also📖Economic Burden — Neurodegeneration60%

see_also📖European Neurodegeneration Epidemiology60%

see_also📖Familial vs Sporadic Neurodegeneration Comparison60%

see_also📖Global Neurodegeneration Epidemiology60%

see_also📖India Neurodegeneration Epidemiology60%

see_also📖Japan Neurodegeneration Epidemiology60%

see_also📖Manganese-Related Neurodegeneration (Manganism)60%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison60%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr60%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 60%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)60%

see_also📖Potential Impact Measures — Neurodegeneration60%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)60%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)60%

see_also📖Sleep Disorders in Neurodegeneration60%

see_also📖US Neurodegeneration Epidemiology60%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread60%

see_also📖acetylcholine-signaling-neurodegeneration60%

see_also📖Advanced Glycation End Products in Neurodegeneration60%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 60%

see_also📖Amylin Signaling in Neurodegeneration60%

see_also📖Antibody Therapy in Neurodegeneration60%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration60%

see_also📖Autosis Pathway in Neurodegeneration60%

see_also📖Axon Guidance Pathways in Neurodegeneration60%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration60%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain60%

see_also📖CaMKII Signaling Pathway in Neurodegeneration60%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration60%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration60%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration60%

see_also📖Cholinergic System Dysfunction in Neurodegeneration60%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat60%

see_also📖Neural Circuits in Neurodegeneration60%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration60%

see_also📖Computational Disease Models for Neurodegeneration60%

see_also📖Convergent Pathways in Neurodegeneration60%

see_also📖Copper Homeostasis in Neurodegeneration60%

see_also📖COVID-19 Neurodegeneration Mechanism60%

see_also📖Diffusion MRI (DTI) in Neurodegeneration60%

see_also📖Digital Phenotyping in Neurodegeneration60%

see_also📖Down Syndrome Neurodegeneration Pathway60%

see_also📖Dystrophic Neurites in Neurodegeneration60%

see_also📖Endocannabinoid System in Neurodegeneration60%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration60%

see_also📖Endosomal Sorting Defects in Neurodegeneration60%

see_also📖Endothelin Signaling Pathway in Neurodegeneration60%

see_also📖epigenetics-neurodegeneration60%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration60%

see_also📖FA2H-Associated Neurodegeneration Pathway60%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration60%

see_also📖Galectin-3 Mechanism in Neurodegeneration60%

see_also📖Gangliosides in Neurodegeneration60%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration60%

see_also📖GDNF Signaling Pathway in Neurodegeneration60%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration60%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration60%

see_also📖Glycosylation in Neurodegeneration60%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration60%

see_also📖Hippocampal Neurogenesis in Neurodegeneration60%

see_also📖Histone Modification Pathways in Neurodegeneration60%

see_also📖HMGB1 Signaling in Neurodegeneration60%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration60%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration60%

see_also📖IL-1 Signaling Pathway in Neurodegeneration60%

see_also📖Integrated Stress Response in Neurodegeneration60%

see_also📖interleukin-6-signaling-neurodegeneration60%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration60%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 60%

see_also📖Kidney-Brain Neurodegeneration Axis60%

see_also📖Lipid Dysregulation in Neurodegeneration60%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration60%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration60%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration60%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration60%

see_also📖Metal Homeostasis in Neurodegeneration60%

see_also📖Microglial Priming Pathway in Neurodegeneration60%

see_also📖MicroRNA Dysfunction in Neurodegeneration60%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration60%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration60%

see_also📖Mitochondrial Fusion in Neurodegeneration60%

see_also📖Molecular Chaperones in Neurodegeneration60%

see_also📖mTOR Signaling in Neurodegeneration60%

see_also📖mTOR Signaling Pathway in Neurodegeneration60%

see_also📖Neural Circuit Disruption in Neurodegeneration60%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N60%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati60%

see_also📖Neuronal Hyperexcitability in Neurodegeneration60%

see_also📖Neuropil Threads in Neurodegeneration60%

see_also📖Neurotensin Signaling in Neurodegeneration60%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration60%

see_also📖NF-kB Signaling Pathway in Neurodegeneration60%

see_also📖Nitric Oxide Signaling in Neurodegeneration60%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration60%

see_also📖Neuropeptide Y Signaling in Neurodegeneration60%

see_also📖NRF2 Signaling Pathway in Neurodegeneration60%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration60%

see_also📖Orexin Signaling in Neurodegeneration60%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration60%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration60%

see_also📖Paranodal Dysfunction in Neurodegeneration60%

see_also📖Paraptosis in Neurodegeneration60%

see_also📖Parthanatos in Neurodegeneration60%

see_also📖Pericyte Loss in Neurodegeneration60%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration60%

see_also📖PKR Pathway in Neurodegeneration60%

see_also📖PPAR Signaling Pathway in Neurodegeneration60%

see_also📖Prion Diseases in Neurodegeneration60%

see_also📖Prion-Like Spread in Neurodegeneration60%

see_also📖Prion Protein Metabolism in Neurodegeneration60%

see_also📖Progesterone Signaling Pathway in Neurodegeneration60%

see_also📖Prognostic Biomarkers in Neurodegeneration60%

see_also📖Protein Aggregation Comparison in Neurodegeneration60%

see_also📖Protein Aggregation Seeds in Neurodegeneration60%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration60%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su60%

see_also📖Purinergic Signaling in Neurodegeneration60%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener60%

see_also📖R-Loop Stress in Neurodegeneration60%

see_also📖RAN Translation in Neurodegeneration60%

see_also📖Retinal Degeneration Pathway in Neurodegeneration60%

see_also📖Ribosome Dysfunction in Neurodegeneration60%

see_also📖RNA Splicing in Neurodegeneration60%

see_also📖RNA-Targeted Therapies in Neurodegeneration60%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a60%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration60%

see_also📖Senescent Cell Clearance in Neurodegeneration60%

see_also📖Serotonergic Dysfunction in Neurodegeneration60%

see_also📖Sex Differences in Neurodegeneration60%

see_also📖Short Chain Fatty Acids in Neurodegeneration60%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration60%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration60%

see_also📖Sleep Dysfunction in Neurodegeneration60%

see_also📖SUMOylation in Neurodegeneration60%

see_also📖synaptic-vesicle-cycling-neurodegeneration60%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration60%

see_also📖T-Cell Dysfunction in Neurodegeneration60%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration60%

see_also📖Therapeutic Targets in Neurodegeneration60%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration60%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration60%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration60%

see_also📖Vagus Nerve Pathway in Neurodegeneration60%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio60%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio60%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen60%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration60%

mentions🧪APOE Isoform Conversion Therapy60%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy60%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 60%

related🧪APOE Isoform Conversion Therapy54%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy54%

related🔬What are the mechanisms underlying mechanistic role of apoe 54%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%

mentions🧫Multi-omics analysis of myricanol effects on gene expression50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa50%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%

related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea50%

related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%

related🔬Mitochondrial transfer between astrocytes and neurons50%

related🧪Mitochondrial RNA Granule Rescue Pathway50%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement50%

related🧪Piezoelectric Nanochannel BBB Disruption50%

related🧪Axonal RNA Transport Reconstitution50%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

related🧪Pharmacological Enhancement of APOE4 Glycosylation50%

related🧪RNA Granule Nucleation Site Modulation50%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime50%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di50%

see_also📖al002-trem2-agonist-alzheimers45%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD45%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat45%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial45%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)45%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month45%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M45%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial45%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717045%

see_also📖UB-311 Alzheimer's Vaccination Trial45%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

mentions🔬What are the mechanisms underlying mitochondrial transfer be40%

mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa40%

mentions🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%

mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%

mentions🔬Mitochondrial transfer between astrocytes and neurons40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

related🧪Senescent Cell Mitochondrial DNA Release40%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%

related🧪APOE Isoform Conversion Therapy35%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho35%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes35%

related🧪Proteostasis Enhancement via APOE Chaperone Targeting35%

related🧪APOE Isoform Expression Across Glial Subtypes35%

related🔬What are the mechanisms underlying selective vulnerability o30%